Feature | October 05, 2010

Ongoing Progress to Target Tumors

This article appeared as an introduction to the image-guided radiotherapy (IGRT) comparison chart in the October 2010 issue of Imaging Technology News.

Of the many ongoing efforts to minimize dose to healthy tissue and target radiation to hit only tumors, image-guided radiotherapy (IGRT) is one of those at the forefront. New features and software are being offered and updated by major systems vendors, as IGRT is being used to help treat cancers throughout the body.

It has always been a challenge for radiation oncologists to achieve tumor location that is 100 percent precise, either because of patient shifts in position, tumor movement due to body functions like respiration, or tumor changes during the treatment series. IGRT helps to overcome these challenges, in some cases even providing tumor localization in real-time, spanning the fourth dimension.

This year has seen a number of developments and improvements in IGRT systems, including the following:

- Exhibited for the first time at this year’s American Association of Physicists in Medicine (AAPM) show, the TrueBeam IGRT and radiosurgery system synchronizes imaging, patient positioning, motion management and treatment delivery. The system delivers dose more than twice as fast as other linear accelerators, Varian says.

There currently are two cancer centers worldwide using the TrueBeam system. One is the University of Zurich, which began using it clinically in March to treat prostate, lung cancer, brain and spinal metastases and benign nerve sheath tumors. There also are plans to extend treatments for lung and upper gastrointestinal tract cancers, along with palliative treatments.

- Resonant Medical, a company recently acquired by Elekta, has IGRT systems for soft tissues like breast and prostate, using 3-D ultrasound technology. It compares 3-D structures, not images, to provide accurate guidance noninvasively, without additional dose or any compromise to throughput. The Clarity System is FDA-cleared and compatible with many models of linear accelerators and computed tomography (CT) scanners.

- The Artiste Solution from Siemens is a linear accelerator with a portfolio of image-guided delivery tools, so that a clinician can choose the optimal IGRT application for the preferred treatment approach. These include 3-D megavoltage cone beam imaging and in-room CT.
In addition, Siemens recently entered into an agreement with Calypso Medical Technologies to sell the Calypso system in Europe. Calypso’s GPS for the Body is a real-time localization technology; when the tumor moves outside of the field of radiation, therapy can be stopped while the patient is repositioned to ensure that the tumor, not the surrounding healthy tissue, receives the radiation dose.

- Another real-time patient positioning tool is the ExacTrac infrared monitoring device, which tracks the patient’s position throughout treatment delivery. The ceiling-mounted device from Brainlab is available as an add-on to existing treatment machines. ExacTrac offers high-resolution stereoscopic X-ray imaging to target tumors and correct patient positioning.

- The Protura robotic positioning system can integrate with an existing IGRT solution and linear accelerator to provide an all-in-one motion management solution. From Civco Medical Solutions, Protura has a built-in redundant sensor system that is used for auto-calibration and assures the robot precisely aligns the patient without needing an external camera system.

- Some IGRT systems involve the use of fiducials for tracking tumors and positioning patients for treatment. FlexiMarc and FlexiCoil, used primarly for IGRT, are the first implanted fiducials designed with image projection and marker stability as the primary objectives. Node-based technology projects a nonbiological image, providing a reference for accurate localization. Both the human eye and software programs can identify FlexiMarc and FlexiCoil.

Research Takes a Stock Market Approach
In an interesting approach to tracking tumors, one new model is being developed employing tactics similar to those used by stock market analysts to estimate the rise and fall of stocks. Dan Ruan, Ph.D., an instructor in radiation oncology at Stanford University, presented her approach during the recent AAPM meeting.

With a typical IGRT protocol, X-rays are used at fixed frequency to validate the location of the tumor target. This rate may be increased to improve the localization accuracy. Ruan’s model, however, which she calls adaptive, aims to accurately localize tumors in real-time by imaging smarter, rather than more frequently. It makes online decisions as to whether or not it is necessary to take a new X-ray image during treatment. She presented test cases where imaging frequency was reduced by 40 to 50 percent without sacrificing tumor localization accuracy.1

Reference:
1. D. Ruan, “Reducing Imaging Dose without Sacrificing Target Localization Accuracy: A Feasibility Study.” Research supported by the National Cancer Institute and AAPM Seed Funding Initiative.

 

Related Content

Selecting an AI Marketplace for Radiology: Key Considerations for Healthcare Providers
Feature | Artificial Intelligence | October 18, 2019
October 18, 2019 — As the nascent market for...
Surgical Institute of Reading Chooses RamSoft's PowerServer Lite PACS
News | PACS | October 18, 2019
Surgical Institute of Reading recently selected RamSoft’s PowerServer Lite PACS (picture archiving and communication...
MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
While electronic medical record systems have helped consolidate most patient data into one location, medical imaging IT systems has proved to be more difficult to replicate by large EMR vendors. This has made room in the market for third-party radiology IT vendors that allow easy integration with the larger EMRs like Epic and Cerner. This image shows Agfa's enterprise imaging system, leveraging its ability to be accessed anywhere with internet connection and pull images from radiology and surgery.

While electronic medical record systems have helped consolidate most patient data into one location, medical imaging IT systems has proved to be more difficult to replicate by large EMR vendors. This has made room in the market for third-party radiology information system vendors that allow easy integration with the larger EMRs like Epic and Cerner. This image shows Agfa's enterprise imaging system, leveraging its ability to be accessed anywhere with an internet connection and able to pull in images from both radiology and surgery. 

Feature | Enterprise Imaging | October 17, 2019 | Steve Holloway
October 17, 2019 — The growing influence and uptake of electronic medical records (EMRs) in healthcare has driven deb
USF Health Expands Digisonics System With Vascular Reporting
News | Cardiac PACS | October 17, 2019
University of South Florida (USF) Health in Tampa, Fla., has enhanced their use of the Digisonics Cardiovascular...
Intelerad's nuage Patient Portal

Intelerad's nuage Patient Portal. Image courtesy of Intelerad.

News | Enterprise Imaging | October 17, 2019
Intelerad Medical Systems announced that OneWelbeck, a London operator of specialist facilities for minimally-invasive...
An illustration of radiology department analytics data showing GE Healthcare’s business analytics software.

An illustration of radiology department analytics data showing GE Healthcare’s business analytics software.

Feature | Radiology Business | October 17, 2019 | By April Wilson
According to IBM, the world creates 2.5 quintillion bytes of data daily.
Image courtesy of Bethesda Health

Image courtesy of Bethesda Health

Feature | Radiology Business | October 17, 2019 | By Susan DeCathelineau
Few professions have experienced the dramatic changes that radiologists have over the past few years.
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage prost
Using Compressed SENSE for faster MRI scans, healthcare providers can transform their radiology workflow.

Using Compressed SENSE for faster MRI scans, healthcare providers can transform their radiology workflow.

Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | October 16, 2019
Since the introduction of magnetic resonan...